Societal economic burden of multiple sclerosis and cost-effectiveness of disease-modifying therapies

BACKGROUND: In an era of scarce resources, policy makers, neurologists and other stakeholders need to be aware of the economic burden of multiple sclerosis and the cost-effectiveness of disease-modifying therapies. The aim of this article is to provide a mini-review of these health economic facets o...

Descripción completa

Detalles Bibliográficos
Autor principal: Simoens, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631775/
https://www.ncbi.nlm.nih.gov/pubmed/36341111
http://dx.doi.org/10.3389/fneur.2022.1015256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631775/
https://www.ncbi.nlm.nih.gov/pubmed/36341111
http://dx.doi.org/10.3389/fneur.2022.1015256

Ejemplares similares